JAZZ
Jazz Pharmaceuticals plc · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -1.6% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 135 | +4 | 47.42M | $11.41B | +7 | −4 |
| Q1 2026 | 135 | -10 | 49.63M | $8.67B | +4 | −14 |
| Q4 2025 | 144 | +2 | 48.56M | $7.62B | +2 | — |
| Q3 2025 | 20 | 0 | 25.68M | $3.38B | +1 | −1 |
| Q2 2025 | 17 | -1 | 21.49M | $2.28B | +1 | −2 |
| Q1 2025 | 15 | 0 | 8.34M | $1.04B | +1 | −1 |
| Q4 2024 | 15 | 0 | 8.56M | $1.05B | +1 | −1 |
| Q3 2024 | 14 | -2 | 7.38M | $822.21M | — | −2 |
| Q2 2024 | 16 | — | 7.74M | $826.28M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 5.91M | -3.0% | $778.54M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 5.56M | -4.2% | $732.72M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | JPMorgan Chase ✦ | 3.73M | — | $492.18M | 0.0% | n/c | 1 | SEC ↗ ×24 |
| 4 | Capital World Investors ✦ | 2.55M | +0.4% | $336.73M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passief) | 1.87M | -3.5% | $246.19M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passief) | 1.20M | +2.1% | $157.67M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 924.87K | +2.7% | $121.90M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 883.95K | +42.1% | $116.50M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 717.62K | — | $94.58M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 10 | AQR Capital Management ✦ | 698.94K | -12.1% | $90.96M | 0.1% | ▼ Trim | 6 | SEC ↗ ×4 |
| 11 | Fidelity (FMR) ✦ | 682.14K | +24.6% | $89.91M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 269.11K | -59.3% | $35.47M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Goldman Sachs Group ✦ | 165.07K | — | $21.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 153.00K | +13.3% | $20.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 129.20K | +8.2% | $17.03M | 0.0% | ▲ Add | 6 | SEC ↗ ×7 |
| 16 | D. E. Shaw & Co. ✦ | 124.37K | +3084.0% | $16.39M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 51.19K | -25.2% | $6.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 46.70K | +6.0% | $6.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 11.86K | Nieuw | $1.56M | 0.0% | New | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 4.17K | -90.8% | $550,001 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $1.56M | 0.0% |
Verlaten
| Marshall Wace | $698,057 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 568 houders, 63.82M aandelen, $11.28B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director · 2.00K aand · $472,800
Director · 6.00K aand · $1.38M
Officer · 1.20K aand · $289,128
Officer · 2.00K aand · $486,060
Director · 6.00K aand · $1.50M
Officer · 300 aand · $75,828
Officer · 18.11K aand · $4.53M
Officer · 9.26K aand · $2.33M
Officer · 11.42K aand · $2.84M
Officer · 18.19K aand · $4.51M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie